Search by Drug Name or NDC
NDC 69076-0913-25 Mercaptopurine 50 mg/1 Details
Mercaptopurine 50 mg/1
Mercaptopurine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Quinn Pharmaceuticals. The primary component is MERCAPTOPURINE.
MedlinePlus Drug Summary
Mercaptopurine is used alone or with other chemotherapy drugs to treat acute lymphocytic leukemia (ALL; also called acute lymphoblastic leukemia and acute lymphatic leukemia; a type of cancer that begins in the white blood cells). Mercaptopurine is in a class of medications called purine antagonists. It works by stopping the growth of cancer cells.
Related Packages: 69076-0913-25Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Mercaptopurine
Product Information
| NDC | 69076-0913 |
|---|---|
| Product ID | 69076-913_0e0eee20-c44e-6528-e063-6294a90a2e04 |
| Associated GPIs | 21300040000305 |
| GCN Sequence Number | 008802 |
| GCN Sequence Number Description | mercaptopurine TABLET 50 MG ORAL |
| HIC3 | V1B |
| HIC3 Description | ANTINEOPLASTIC - ANTIMETABOLITES |
| GCN | 38520 |
| HICL Sequence Number | 003908 |
| HICL Sequence Number Description | MERCAPTOPURINE |
| Brand/Generic | Generic |
| Proprietary Name | Mercaptopurine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Mercaptopurine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/1 |
| Substance Name | MERCAPTOPURINE |
| Labeler Name | Quinn Pharmaceuticals |
| Pharmaceutical Class | Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA AUTHORIZED GENERIC |
| Application Number | NDA009053 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 69076-0913-25 (69076091325)
| NDC Package Code | 69076-913-25 |
|---|---|
| Billing NDC | 69076091325 |
| Package | 250 TABLET in 1 BOTTLE, PLASTIC (69076-913-25) |
| Marketing Start Date | 2016-10-05 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.88163 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | MERCAPTOPURINE 50 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 6 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis